Malaysia Pharmaceuticals & Healthcare Q1 2019
We maintain a modest growth outlook for the Malaysian pharmaceutical market which will gradually slow over ourforecast period as government policies continue to repress medicine sales. Innovative drug demand will be largely driven by theunmet need for non-communicable disease treatments and the government's commitment to healthcare. However, concerns overthe price of pharmaceuticals and their net impact on total expenditure will see the government continue to intervene and establishdrug price controls to achieve better transparency and cost efficiency in the procurement of medicines.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook